Eustachian salpingitis and obstruction

H8_EUSTSALP

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H68 Hospital discharge: ICD-9 — 3816 Hospital discharge: ICD-8 — 3840[0-2] Cause of death: ICD-10 — H68 Cause of death: ICD-9 — 3816 Cause of death: ICD-8 — 3840[0-2] 2 out of 7 registries used, show all original rules.	3449
4. Check minimum number of events None	3449
5. Include endpoints None	3449
6. Filter based on genotype QC (FinnGen only)	3449

Control definitions (FinnGen only)

Control exclude: H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4

NAME	H8_EUSTSALP
CONTROL_EXCLUDE	H8_MIDDLEMASTOID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H68[0-1]
HD_ICD_9	3816
HD_ICD_8	3840[0-2]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H68[0-1]
COD_ICD_9	3816
COD_ICD_8	3840[0-2]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Eustachian salpingitis and obstruction based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31754	13543	18131
Only index persons	30023	12880	17143
Unadjusted period prevalence (%)
Whole population	0.45	0.39	0.51
Only index persons	0.58	0.47	0.65
Median age at first event (years)
Whole population	5.11	5.81	4.58
Only index persons	5.10	5.83	4.54

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3449	1936	1513
Unadjusted period prevalence (%)	0.66	0.66	0.67
Median age at first event (years)	6.49	6.85	6.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3120: Matched controls
31201

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

38400

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) acuta

+∞

323.0

434

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

148.6

323.0

830

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

+∞

323.0

368

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

21.0

323.0

1748

1789

38401

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva

+∞

323.0

704

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

291.3

323.0

338

38402

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita

+∞

323.0

1177

4122

FHL

Tympanostomy (tympanic tube)

126.0

287.2

307

H65.3

ICD-10 Finland

Chronic mucoid otitis media

192.2

286.9

296

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

353.2

227.1

227

DGW00

NOMESCO Finland

Dilatation of eustachian tube

2043.5

210.7

202

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

+∞

202.3

192

UDC00

NOMESCO Finland

Ear microscopy

7.7

183.0

455

673

H66.0

ICD-10 Finland

Acute suppurative otitis media

7.4

178.4

457

706

H65.2

ICD-10 Finland

Chronic serous otitis media

238.6

176.3

180

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

55.6

170.3

203

DFF00

NOMESCO Finland

Pure tone audiometry

5.9

128.1

385

723

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

+∞

121.7

116

Z01.1

ICD-10 Finland

Examination of ears and hearing

4.2

120.1

514

1407

H66.9

ICD-10 Finland

Otitis media, unspecified

5.6

110.5

344

670

DC1AD

NOMESCO Finland

Temporalbone CT

32.5

107.6

143

DCD00

NOMESCO Finland

Myringoplasty

+∞

103.7

H71

ICD-10 Finland

Cholesteatoma of middle ear

255.5

97.2

H68.0

ICD-10 Finland

Eustachian salpingitis

84.5

94.7

106

H74.1

ICD-10 Finland

Adhesive middle ear disease

+∞

86.9

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

41.3

76.5

4451

FHL

Guitar cutting

4.7

64.1

229

512

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

62.6

1686

11987

R01AD08

ATC

fluticasone; nasal

2.0

61.1

1051

6312

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

64.1

59.6

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

15.3

56.2

H65.0

ICD-10 Finland

Acute serous otitis media

11.6

56.0

106

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.4

53.1

282

895

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

6.1

50.1

141

239

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.0

49.8

817

4744

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

+∞

49.1

4141

FHL

Myringoplasty (also for reasons other than inflammation)

238.5

46.1

R01AD09

ATC

mometasone; nasal

1.7

45.1

1507

10997

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

121.8

44.9

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

+∞

43.8

H92.0

ICD-10 Finland

Otalgia

3.3

42.7

228

724

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

35.9

41.3

TDA90

NOMESCO Finland

Removal wax from ear

13.4

40.4

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.7

39.0

278

1072

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

25.6

38.0

3842A

ICD-9 Finland

Other disorders of tympanic membrane, Perforation of tympanic membrane

+∞

37.6

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

8.9

36.0

H70.1

ICD-10 Finland

Chronic mastoiditis

+∞

34.4

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

19.6

34.4

74900

ICD-8 Finland

Cleft palate and cleft lip, Cleft palate

29.2

34.2

J01FA10

ATC

azithromycin; systemic

1.6

33.4

1818

14611

3821A

ICD-9 Finland

Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media

+∞

33.4

H01

ICPC

Ear pain/earache

2.2

33.0

357

1709

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

+∞

32.3

H66

ICD-10 Finland

Suppurative and unspecified otitis media

4.5

32.1

118

272

38199

ICD-8 Finland

Otitis media without mention of mastoiditis, Unspecified

+∞

31.3

J01CA04

ATC

amoxicillin; systemic

1.7

30.7

2476

21734

4121

FHL

Tympanic puncture or parasentosis in general anesthesia or operating room

9.9

30.1

H02AB06

ATC

prednisolone; systemic

1.6

29.3

1214

9017

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

5.4

28.8

166

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

28.2

906

6297

R01AD12

ATC

fluticasone furoate; nasal

1.6

27.5

1024

7381

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.4

27.5

254

1126

4452

FHL

Tonsil surgery

2.8

27.1

178

651

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

+∞

27.1

J01DA01

ATC

[U] cefalexin; systemic

1.5

26.8

1810

14918

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.4

25.6

225

972

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.0

25.0

148

504

3853A

ICD-9 Finland

Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid

+∞

24.0

S02CA02

ATC

flumetasone and antiinfectives; otic

2.9

23.7

152

548

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

8.4

23.6

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

54.4

23.1

H69.0

ICD-10 Finland

Patulous Eustachian tube

20.2

23.0

EMB30

NOMESCO Finland

Adenotomy

5.4

23.0

133

H29

ICPC

Ear symptom/complaint other

2.2

22.9

237

1108

ZXE00

NOMESCO Finland

One hour or less

1.5

22.9

1108

8390

H60.8

ICD-10 Finland

Other otitis externa

3.7

22.5

100

276

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

22.5

688

4676

DCD10

NOMESCO Finland

Tympanoplasty

115.8

21.6

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.3

21.0

106

325

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

20.9

901

6621

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

7.1

20.8

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

9.4

20.5

H69.8

ICD-10 Finland

Other specified disorders of Eustachian tube

20.2

20.4

ZXA10

NOMESCO Finland

Bilateral

1.8

20.0

406

2448

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.2

19.9

105

333

DEB30

NOMESCO Finland

Radical mastoidectomy

+∞

19.8

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

11.0

19.6

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

19.4

180

799

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

22.7

19.0

J01FA09

ATC

clarithromycin; systemic

1.5

18.8

889

6634

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

+∞

18.8

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

3.4

18.7

277

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

18.7

280

1525

1450

FHL

Otomicroscopy

9.0

18.6

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

38.6

18.5

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

4.0

18.4

184

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

36.9

17.6

J01DB01

ATC

cefalexin; oral

1.5

17.5

2417

21901

J01DA08

ATC

[U] cefaclor; oral

1.8

17.4

292

1650

DFF15

NOMESCO Finland

Speech audiometry

3.5

17.4

245

H13

ICPC

Plugged feeling ear

1.8

17.3

325

1910

J01AA02

ATC

doxycycline; systemic

1.4

17.0

2124

18817

DEA10

NOMESCO Finland

Attico-antrotomy

+∞

16.7

R03AC02

ATC

salbutamol; inhalant

1.4

16.7

1455

12100

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

2.4

16.5

144

622

DFF10

NOMESCO Finland

Measurement of acoustic impedance (tympanometry and reflex testing)

18.0

16.4

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

16.4

193

955

SPAT1043

SPAT

Audiometry

2.3

15.9

156

710

J01DA06

ATC

[U] cefuroxime; systemic

1.7

15.7

374

2358

H71

ICPC

Acute otitis media/myringitis

4.5

15.6

124

J32.4

ICD-10 Finland

Chronic pansinusitis

4.0

15.5

153

H60.3

ICD-10 Finland

Other infective otitis externa

3.6

15.5

198

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

15.5

143

634

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.0

15.5

313

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

15.4

359

H02AB04

ATC

methylprednisolone; systemic

1.7

15.4

339

2088

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

15.3

573

4042

H02

ICPC

Hearing complaint

2.1

15.3

171

829

UDM02

NOMESCO Finland

Sinoscopy

3.3

15.2

244

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.2

14.9

248

Z96.2

ICD-10 Finland

Presence of otological and audiological implants

56.9

14.8

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

+∞

14.6

H72.1

ICD-10 Finland

Attic perforation of tympanic membrane

80.5

14.6

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

14.3

119

503

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

14.0

845

6541

Z97.4

ICD-10 Finland

Presence of external hearing-aid

3.5

13.7

187

DCW00

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

75.5

13.6

4150

FHL

Tympanoplasty (including for reasons other than inflammation)

+∞

13.5

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

+∞

13.5

R06.0

ICD-10 Finland

Dyspnoea

1.5

13.5

485

3379

4364

FHL

Pharyngeal tongue plastic

25.8

13.4

Q35.1

ICD-10 Finland

Cleft hard palate

21.2

13.3

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

13.3

659

4907

N07CA01

ATC

betahistine; oral

2.2

13.2

135

628

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.7

13.1

348

48509

ICD-8 Finland

Bronchopneumonia, unspecified

3.6

13.1

168

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

13.0

240

1399

H60.4

ICD-10 Finland

Cholesteatoma of external ear

14.1

12.7

H61.2

ICD-10 Finland

Impacted cerumen

2.3

12.7

119

535

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

12.6

903

7170

38299

ICD-8 Finland

Unspecified otitis media with mastoiditis

+∞

12.5

7490A

ICD-9 Finland

Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]

37.7

12.2

A02BC02

ATC

pantoprazole; systemic

1.3

12.1

1554

13450

R06AE07

ATC

cetirizine; oral

1.3

12.0

1239

10389

R42

ICD-10 Finland

Dizziness and giddiness

1.5

12.0

400

2738

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.7

11.9

302

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

4.7

11.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

11.7

390

2667

48609

ICD-8 Finland

Pneumonia, unspecified

3.0

11.7

227

4129

FHL

Other measure in this category

30.1

11.6

R01AD11

ATC

triamcinolone; nasal

1.7

11.6

227

1348

H61.8

ICD-10 Finland

Other specified disorders of external ear

5.1

11.5

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.6

11.5

272

1707

H73.1

ICD-10 Finland

Chronic myringitis

+∞

11.5

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

+∞

11.5

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

11.5

212

1239

1451

FHL

Otomicroscopy and paper place

120.4

11.4

4224

FHL

Endonasal anthrostomy

4.5

11.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

11.4

644

4902

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

3.5

11.3

152

A02BC05

ATC

esomeprazole; systemic

1.3

11.3

938

7597

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

11.2

946

7682

4740A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Chronic tonsillitis

2.1

11.1

129

638

H60

ICD-10 Finland

Otitis externa

2.0

10.9

139

713

J01FF01

ATC

clindamycin; systemic

1.4

10.9

656

5042

G47.3

ICD-10 Finland

Sleep apnoea

1.4

10.9

486

3534

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

10.8

343

2322

J35.2

ICD-10 Finland

Hypertrophy of adenoids

3.6

10.8

132

J01DC02

ATC

cefuroxime; systemic

1.9

10.6

161

883

D82

ICPC

Teeth/gum disease

1.3

10.5

995

8196

38200

ICD-8 Finland

Acute / Acute otitis media with mastoiditis

+∞

10.4

H74.2

ICD-10 Finland

Discontinuity and dislocation of ear ossicles

+∞

10.4

4145

FHL

Tympanomastoidectomy, includes possible tympanoplasty

+∞

10.4

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

10.4

155

844

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

16.1

10.3

H72

ICD-10 Finland

Perforation of tympanic membrane

32.6

10.3

H69.9

ICD-10 Finland

Eustachian tube disorder, unspecified

8.2

10.3

74920

ICD-8 Finland

Cleft palate and cleft lip, Cheilognathopalatoschisis unilateralis

18.8

10.3

4741A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PALATINAE]

4.2

10.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

10.1

863

6995

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

10.1

238

1494

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

4.0

10.1

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

10.0

850

6882

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

10.0

1472

12839

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

10.0

185

1085

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

3.4

10.0

141

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

9.9

137

725

50709

ICD-8 Finland

Hay fever, Unspecified

6.7

9.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

9.8

1013

8426

ZFX00

NOMESCO Finland

Use of balloon dilatation

20.1

9.8

N02BE01

ATC

paracetamol; systemic, rectal

1.3

9.8

2303

21313

R01AD05

ATC

budesonide; nasal

1.7

9.7

203

1229

H04

ICPC

Ear discharge

2.7

9.7

252

M01AE02

ATC

naproxen; oral, rectal

1.3

9.7

1528

13423

J01MA12

ATC

levofloxacin; systemic

1.5

9.7

345

2395

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

9.6

494

3684

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

9.6

1541

13561

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

2.0

9.6

116

586

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.4

9.4

313

R01AD01

ATC

beclometasone; nasal

1.4

9.4

410

2961

4151

FHL

Reoperation for chronic otitis media

100.3

9.4

R06AX27

ATC

desloratadine; oral

1.3

9.4

801

6477

4144

FHL

Mastoidectomy or aticomastoidectomy

+∞

9.4

H74.0

ICD-10 Finland

Tympanosclerosis

+∞

9.4

7490B

ICD-9 Finland

Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS INCOMPLETA]

+∞

9.4

R5120

NOMESCO Finland

Preparation of an aid

3.4

9.2

129

WX723

NOMESCO Finland

CPAP therapy

2.1

9.0

460

SPAT1263

SPAT

Sampling

1.3

8.9

1047

8838

H02AB07

ATC

prednisone; oral

1.5

8.8

298

2043

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

8.8

204

1277

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

8.8

382

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

50.1

8.7

R03DC03

ATC

montelukast; oral

1.4

8.6

413

3035

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

8.6

660

5245

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

8.6

475

3580

S02AA03

ATC

boric acid; otic

5.2

8.6

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

8.6

424

3135

ZXA00

NOMESCO Finland

Right side

1.4

8.6

484

3667

J02AC01

ATC

fluconazole; systemic

1.3

8.5

1078

9170

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

8.5

1179

10140

7492A

ICD-9 Finland

Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS UNILATERALIS COMPLETA]

20.1

8.5

74929

ICD-8 Finland

Cleft palate and cleft lip, Unspecified

90.3

8.4

J01FA01

ATC

erythromycin; systemic

1.4

8.4

398

2921

J01FA15

ATC

telithromycin; oral

1.5

8.4

252

1684

Q37.1

ICD-10 Finland

Cleft hard palate with unilateral cleft lip

12.8

8.4

3811A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic serous otitis media

+∞

8.3

DCA40

NOMESCO Finland

Fat patching or other similar technique without opening of tympanic membrane

+∞

8.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

8.3

569

4442

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

8.3

947

7943

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

8.3

119

643

L15

ICPC

Knee symptom/complaint

1.4

8.2

376

2744

SPAT1153

SPAT

Removal of sutures

1.3

8.1

599

4734

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

8.0

399

A02BC01

ATC

omeprazole; systemic

1.3

8.0

546

4256

M03BX02

ATC

tizanidine; oral

1.2

8.0

1782

16147

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

7.9

686

5544

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.3

7.9

308

J01FA06

ATC

roxithromycin; oral

1.3

7.9

988

8378

EMB10

NOMESCO Finland

Tonsillectomy

1.6

7.8

214

1396

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

7.8

119

658

DPA30

NOMESCO Finland

Sphenotomy

4.8

7.7

H93.2

ICD-10 Finland

Other abnormal auditory perceptions

4.4

7.7

R51.80

ICD-10 Finland

Headache

1.4

7.7

392

2912

DHB50

NOMESCO Finland

Turbinoplasty

2.0

7.7

444

UJF32

NOMESCO Finland

Coloscopy

1.4

7.7

451

3432

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

7.7

380

2810

S02AA30

ATC

antiinfectives, combinations; otic

2.0

7.6

460

H65

ICD-10 Finland

Nonsuppurative otitis media

3.7

7.6

WX402

NOMESCO Finland

General anaesthesia

1.4

7.6

396

2956

M01AH05

ATC

etoricoxib; oral

1.2

7.6

1544

13810

H73.0

ICD-10 Finland

Acute myringitis

8.0

7.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.6

2066

19081

H72

ICPC

Serous otitis media

25.1

7.6

SPAT1211

SPAT

Application of soft bandage

1.6

7.5

172

1074

J01MA02

ATC

ciprofloxacin; systemic

1.3

7.5

807

6699

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

3.8

7.5

J20

ICD-10 Finland

Acute bronchitis

1.6

7.5

210

1380

R03BA05

ATC

fluticasone; inhalant

1.4

7.4

420

3182

ZZG00

NOMESCO Finland

Graft of cartilage

13.4

7.4

WX780

NOMESCO Finland

Remote monitoring CPAP

1.9

7.4

523

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

7.3

449

3442

RK520

NOMESCO Finland

8.4

7.3

3851A

ICD-9 Finland

Other disorders of middle ear and mastoid, Adhesive middle ear disease

+∞

7.3

3816A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Obstruction of Eustachian tube

+∞

7.3

AA1AD

NOMESCO Finland

CT of head and brain

1.4

7.2

388

2910

N02AX02

ATC

tramadol; systemic, rectal

1.3

7.2

891

7528

DC1AI

NOMESCO Finland

Cone beam CT of ear

30.1

7.1

H03AA01

ATC

levothyroxine sodium; systemic

1.3

7.1

470

3643

WX002

NOMESCO Finland

Sedation and analgesia

1.4

7.1

355

2627

SPAT1262

SPAT

Handing over of treatment supplies

1.4

7.1

323

2351

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

6.6

7.1

SPAT1312

SPAT

General health counselling

1.3

7.1

731

6037

05209

ICD-8 Finland

Chickenpox, Unspecified

5.6

7.1

J33.8

ICD-10 Finland

Other polyp of sinus

2.5

7.0

206

WX110

NOMESCO Finland

Local anesthesy

1.2

7.0

1963

18092

R01BA01

ATC

phenylpropanolamine; oral

1.8

7.0

112

632

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

7.0

191

1251

R06AX13

ATC

loratadine; oral

1.3

6.9

426

3273

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

2.3

6.9

241

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

6.7

367

2760

UKC02

NOMESCO Finland

Cystoscopy

1.5

6.6

208

1405

H93.1

ICD-10 Finland

Tinnitus

1.7

6.6

123

728

E0000UV

ATC

1.2

6.6

949

8140

1290

FHL

Epipharyngoscopy

12.3

6.6

R96

ICPC

Asthma

1.6

6.6

159

1012

N03AX12

ATC

gabapentin; oral

1.4

6.5

302

2208

H92.1

ICD-10 Finland

Otorrhoea

10.0

6.5

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

3.6

6.5

R05FB02

ATC

cough suppressants and expectorants

1.3

6.4

761

6379

TDB00

NOMESCO Finland

Removal of foreign body from external auditory canal

70.0

6.4

4362

FHL

Nozzle reconstruction

70.0

6.4

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

6.4

203

1377

DBB00

NOMESCO Finland

Excision of lesion of external auditory canal

14.3

6.4

M01AB05

ATC

diclofenac; systemic, rectal

1.2

6.3

1810

16631

49099

ICD-8 Finland

Bronchitis, unspecified

2.8

6.3

139

WX320

NOMESCO Finland

Spinalanesthesy

1.3

6.3

439

3434

A02BA02

ATC

ranitidine; systemic

1.4

6.3

322

2395

R74

ICPC

Upper respiratory infection acute

1.2

6.3

848

7215

Q90.9

ICD-10 Finland

Down syndrome, unspecified

18.0

6.3

N03AX16

ATC

pregabalin; oral

1.3

6.3

463

3652

4161

FHL

Exploratory tympanotomy

+∞

6.3

H95.0

ICD-10 Finland

Recurrent cholesteatoma of postmastoidectomy cavity

+∞

6.3

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

6.2

505

4030

Q35.9

ICD-10 Finland

Cleft palate, unspecified

26.7

6.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

6.2

542

4372

R03CC02

ATC

salbutamol; systemic

1.7

6.2

117

697

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

6.1

269

1948

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

6.1

552

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

6.1

767

6470

DCA30

NOMESCO Finland

Exploration of middle ear

12.5

6.1

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.0

943

8145

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

514

2950

1.87

34.11

2.0

1.6

—

(3013512) EKG study

834

5511

1.68

33.95

3.3

3.0

—

(42870588) Differential panel, method unspecified - Blood

1150

8722

1.48

23.97

6.2

6.5

—

(3032080) INR in Blood by Coagulation assay

1047

7865

1.48

22.62

7.8

6.4

inr

1.1

0.01

397

2544

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

391

2480

1.65

17.65

3.8

3.5

30.1

30.5

0.26

284

1873

(40761536) Microorganisms panel - Urine sediment

358

2235

1.67

17.17

3.5

3.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

283

1666

1.76

16.80

3.7

3.4

mmol/l

1.2

2.15

253

1466

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

341

2115

1.68

16.75

3.0

2.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1178

9428

1.38

16.68

5.8

5.7

mmol/l

1.2

0.92

1071

8703

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1282

10552

1.34

14.65

6.3

mmol/l

1.2

0.50

1027

8988

(3021589) Normoblasts [#/volume] in Blood

1436

12036

1.33

14.44

9.3

8.4

e9/l

0.0

0.11

1180

9864

(3013707) Erythrocyte sedimentation rate by Westergren method

2192

19519

1.34

14.42

4.2

3.7

mm/h

9.3

9.0

0.68

2044

18434

(3012501) Base excess in Blood by calculation

108

479

2.30

14.32

3.5

3.3

mmol/l

2.3

2.1

0.31

287

(3010421) pH of Blood

121

563

2.19

14.30

3.3

3.5

7.4

0.18

107

468

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

981

7782

1.36

14.18

1.7

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2001

17654

1.32

13.65

4.0

3.7

—

(3022096) Basophils/100 leukocytes in Blood

1476

12486

1.32

13.65

6.5

6.4

0.7

0.48

1383

11808

(3006504) Eosinophils/100 leukocytes in Blood

1519

12905

1.32

13.61

6.4

6.3

2.9

2.8

0.45

1423

12181

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

121

580

2.13

13.29

4.1

3.9

57.9

56.9

0.35

121

580

(3013826) Glucose [Moles/volume] in Serum or Plasma

1599

13739

1.31

12.96

4.6

4.4

mmol/l

6.5

0.34

1471

12667

(3030905) Polymorphonuclear cells [#/volume] in Blood

118

566

2.12

12.95

3.9

3.6

e9/l

3.9

4.0

0.14

118

566

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2154

19280

1.31

12.81

7.3

6.9

u/l

73.4

73.6

0.08

2032

18354

(3019069) Monocytes/100 leukocytes in Blood

1519

12982

1.30

12.73

6.6

6.5

8.2

8.3

0.47

1434

12342

(3018010) Neutrophils/100 leukocytes in Blood

1547

13254

1.30

12.73

6.1

56.6

56.5

0.24

1466

12586

(3002030) Lymphocytes/100 leukocytes in Blood

1562

13444

1.30

12.24

6.5

6.2

29.1

29.3

0.39

1474

12733

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.77

12.12

4.3

4.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

987

8083

1.31

10.92

2.9

2.8

ng/l

33.6

34.7

0.04

505

4016

(3042631) Mycobacterium sp identified in Specimen

205

2.66

10.09

2.6

2.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

559

4259

1.37

9.99

2.7

2.8

ng/l

719.3

881.7

0.65

439

3457

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2986

28358

1.39

9.84

12.3

10.7

mg/l

20.4

20.5

0.05

2353

21676

(3003458) Phosphate [Moles/volume] in Serum or Plasma

380

2717

1.45

9.78

6.5

6.6

mmol/l

1.0

0.15

361

2574

(3026782) Osmolality of Urine

570

4384

1.36

9.57

2.5

mosm/kgh2o

556.5

554.6

0.06

511

3747

(3000494) Fungus identified in Specimen by Culture

410

2990

1.42

9.46

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

423

2.08

9.32

2.5

2.1

17.2

0.05

216

(3019225) pH of Specimen

275

1864

1.52

9.24

3.4

3.7

—

(3001604) Monocytes [#/volume] in Blood

1564

13763

1.25

9.23

6.2

e9/l

0.6

0.04

1379

12198

(3006315) Basophils [#/volume] in Blood

1567

13802

1.25

9.14

6.2

e9/l

0.0

0.26

1381

12204

(40768804) Tissue Pathology biopsy report

1227

10518

1.26

9.06

1.9

—

(3019198) Lymphocytes [#/volume] in Blood

1609

14233

1.24

8.96

6.2

e9/l

2.0

0.07

1451

12832

(3024561) Albumin [Mass/volume] in Serum or Plasma

1131

9619

1.26

8.90

4.8

4.9

g/l

36.8

37.0

0.65

1057

9046

(3003338) MCHC [Mass/volume]

2485

26440

0.78

8.82

14.0

13.4

g/l

333.9

0.01

2465

26267

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1405

12288

1.24

8.54

5.7

5.6

umol/l

10.4

10.8

0.81

1310

11676

(3013115) Eosinophils [#/volume] in Blood

1610

14300

1.24

8.45

6.5

e9/l

0.2

0.77

1447

12877

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

100

535

1.90

8.22

1.3

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2336

21632

1.25

8.17

4.3

3.9

pmol/l

14.5

14.4

0.24

2155

20342

(3005719) IgG [Mass/volume] in Serum or Plasma

305

2166

1.45

8.13

3.2

2.5

g/l

10.2

10.5

0.94

278

2007

(3018418) pH of Serum or Plasma

763

6252

1.28

8.02

4.4

4.0

7.4

0.16

219

1225

(3002179) Metamyelocytes/100 leukocytes in Blood

274

1918

1.47

7.87

4.4

4.3

0.5

0.6

0.12

394

(3012095) Magnesium [Moles/volume] in Serum or Plasma

450

3443

1.35

7.73

3.6

mmol/l

0.8

0.30

429

3240

(3023419) Bacteria identified in Sputum by Culture

222

2.36

7.69

3.9

2.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.14

7.67

1.9

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

145

2.71

7.66

1.7

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

297

2123

1.44

7.65

1.3

u/ml

304.3

225.2

0.30

279

1987

(3028026) IgM [Mass/volume] in Serum or Plasma

241

1655

1.49

7.63

1.8

g/l

1.2

1.3

0.31

223

1560

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2696

25464

1.27

7.50

4.9

4.5

mu/l

1.7

2.0

1.39

2504

24104

(3013650) Neutrophils [#/volume] in Blood by Automated count

1721

15515

1.22

7.44

8.6

9.3

e9/l

4.0

0.02

1500

13747

(3041096) Erythrocytes [Presence] in Urine by Automated

896

7557

1.25

7.30

2.8

2.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

132

796

1.68

7.30

3.3

3.1

mmol/l

24.4

24.8

1.28

127

748

(3019309) Folate [Moles/volume] in Red Blood Cells

428

3287

1.34

7.16

1.9

1.7

nmol/l

1196.9

1158.1

0.35

316

2594

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2563

24116

1.24

7.08

4.9

4.4

mmol/mol

38.2

38.1

0.22

2385

22965

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

225

2.29

7.03

1.5

1.2

u/ml

2.9

0.6

0.88

(3025159) Blasts/100 leukocytes in Blood

267

1903

1.44

6.99

4.5

0.0

0.5

0.98

414

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2313

21543

1.22

6.97

3.2

3.0

u/l

43.5

41.8

0.48

2185

20722

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

184

1218

1.54

6.95

3.3

2.8

mmol/l

1.1

1.5

1.05

143

885

(3009343) pH of Capillary blood

189

1261

1.53

6.89

3.3

2.8

7.4

0.04

164

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.98

6.80

1.9

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

898

7631

1.24

6.76

2.9

2.6

u/l

57.4

56.0

0.29

823

7171

(3021440) Promyelocytes/100 leukocytes in Blood

276

1992

1.42

6.75

4.5

0.1

0.65

487

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1208

10587

1.22

6.74

2.4

2.3

nmol/l

73.5

72.8

0.35

1115

9912

(3024139) IgG subclass 3 [Mass/volume] in Serum

322

2.04

6.73

1.6

1.3

g/l

0.3

0.4

1.11

222

(3035350) Ketones [Presence] in Urine by Test strip

1420

12645

1.21

6.72

3.1

3.0

estimate

0.0

0.88

343

2394

(3028192) IgG subclass 2 [Mass/volume] in Serum

323

2.03

6.67

1.6

1.3

g/l

3.1

0.05

223

(3027135) IgG subclass 1 [Mass/volume] in Serum

323

2.03

6.67

1.6

1.3

g/l

6.1

6.8

1.19

224

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

189

1273

1.51

6.60

3.3

2.8

kpa

5.2

5.1

0.10

179

1195

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

111

2.81

6.57

1.8

1.5

—

(4062490)

325

2.02

6.57

1.6

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

975

8389

1.23

6.48

1.9

1.8

pmol/l

98.8

97.8

0.25

525

4631

(3021601) Nitrite [Presence] in Urine by Test strip

1419

12668

1.20

6.46

4.3

4.2

estimate

0.0

0.24

350

2483

(3022313) Gas panel - Capillary blood

140

888

1.60

6.39

3.2

2.9

—

(40768797) Stomach Pathology biopsy report

419

3274

1.32

6.21

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2857

27335

1.26

6.13

12.6

10.9

mmol/l

139.6

0.02

2780

26643

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2729

25978

1.24

6.11

10.7

9.2

ml/min/173m2

91.7

92.2

0.71

2313

21407

(3036481) Cortisol [Moles/volume] in Serum or Plasma

354

2706

1.34

6.11

2.0

2.1

nmol/l

361.0

362.4

0.05

325

2510

(3009261) Glucose [Presence] in Urine by Test strip

1423

12754

1.20

6.10

3.1

estimate

0.0

0.30

333

2376

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1482

13342

1.19

6.02

3.0

2.9

ug/l

111.9

96.0

0.66

1399

12708

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2713

25824

1.24

6.00

3.9

3.5

mmol/l

5.8

5.7

0.53

2500

24317

(3017181) Myelocytes/100 leukocytes in Blood

283

2095

1.38

5.99

4.5

4.4

0.6

0.9

0.63

529

(1616796) Gas panel - Central venous blood

466

1.80

5.96

4.3

3.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

755

6382

1.23

5.86

1.7

1.6

mmol/l

1.5

1.4

0.49

622

5598

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

129

824

1.59

5.75

1.8

1.6

titre

147.5

314.5

—

(3037522) Nuclear Ab [Titer] in Serum

519

4213

1.27

5.74

1.3

1.4

titre

432.2

554.8

0.76

782

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

356

1.90

5.73

2.1

1.9

—

(3042936) Bacteria identified in Isolate by Culture

418

3307

1.30

5.66

2.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2863

27457

1.25

5.65

12.9

11.0

mmol/l

3.9

0.86

2771

26699

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

504

1.74

5.64

1.9

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1762

16171

1.18

5.57

3.9

3.6

e6/l

1356.7

1089.1

0.07

175

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

222

2.13

5.57

2.4

2.0

mg/l

11.8

26.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

579

4790

1.25

5.44

1.3

u/ml

7.8

9.1

0.22

224

2113

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

762

6500

1.22

5.37

2.0

2.1

u/l

157.6

248.9

2.34

715

6202

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

547

4503

1.26

5.36

1.7

1.6

pmol/l

37104523.2

30182425.1

0.10

442

3956

(3022145) Colonoscopy Study observation

358

2796

1.31

5.33

1.3

1.4

—

(3037121) Protein [Mass/volume] in Urine

120

772

1.57

5.22

2.9

3.5

g/l

0.4

0.21

368

(3007164) IgA [Mass/volume] in Serum or Plasma

738

6302

1.22

5.12

1.5

1.4

g/l

2.2

2.3

1.44

477

4197

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

356

1.84

5.11

1.3

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

685

5814

1.22

5.05

2.2

mg/l

2.7

2.8

0.48

581

5052

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

718

6127

1.22

5.01

1.7

mg/l

0.8

0.9

0.33

523

4406

(3045424) Erythrocytes [Presence] in Urine

395

1.79

5.00

1.2

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

233

2.03

4.95

1.8

1.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

547

1.66

4.95

1.2

1.3

—

6.9

—

(3044640) Blood type and Crossmatch panel - Blood

868

7553

1.20

4.93

2.3

2.2

—

(3004616) Nuclear Ab [Presence] in Serum

318

1.87

4.89

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

664

5649

1.22

4.76

2.3

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

523

1.66

4.73

1.9

1.7

g/l

0.8

0.00

397

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

562

1.64

4.72

1.2

1.3

u/ml

30.3

7.1

—

(3029937) Albumin [Presence] in Urine by Test strip

757

6542

1.20

4.60

3.3

3.4

estimate

0.0

2.03

343

2407

(1761868) Lipid panel - Serum or Plasma

1361

12365

1.17

4.55

2.6

2.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

499

1.66

4.52

2.0

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

263

1.91

4.49

1.6

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

132

899

1.49

4.48

1.5

1.9

g/l

1.2

0.04

125

854

(3020682) Albumin/Creatinine [Ratio] in Urine

669

5734

1.21

4.42

4.7

4.2

mg/mmol

10.3

9.7

0.14

414

3846

(3009445) Proteinase 3 Ab [Units/volume] in Serum

145

1009

1.46

4.42

2.0

1.6

u/ml

6.8

10.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

534

1.63

4.39

2.3

2.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3113

30306

1.28

4.39

9.7

8.6

u/l

29.0

28.4

0.68

3001

29588

(3023368) Bacteria identified in Blood by Culture

622

5300

1.21

4.37

4.5

4.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

127

867

1.48

4.27

1.5

2.0

g/l

0.2

0.23

121

824

(3000570) Elastase.pancreatic [Mass/mass] in Stool

642

1.56

4.23

1.3

1.4

ug/g

293.7

300.1

0.09

326

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

283

1.85

4.23

1.8

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2555

24424

1.18

4.22

3.8

3.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

203

1515

1.36

4.16

1.5

1.7

—

(3012516) Albumin [Mass/volume] in Urine

640

5498

1.20

4.11

3.7

3.4

mg/l

155.9

423.7

1.59

402

3619

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

174

2.08

4.11

1.2

1.1

u/ml

29.3

34.4

—

(3030467) Casts [#/volume] in Urine by Automated count

721

6266

1.19

4.07

3.2

2.8

e6/l

0.2

0.3

0.80

559

4620

(3004775) Volume in Urine collected for unspecified duration

155

2.14

4.05

2.7

2.1

681.8

650.1

0.11

109

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

273

1.84

4.04

1.6

1.5

—

(40768443) Skin Pathology biopsy report

141

995

1.43

4.02

1.2

—

(3019174) dRVVT (LA screen)

3.94

3.97

1.2

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

275

2160

1.30

3.97

3.5

4.4

u/l

235.2

236.0

0.03

265

2060

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.03

3.96

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.03

3.96

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.03

3.96

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

3.03

3.96

1.2

—

(3044889) 12 lead EKG panel

1851

17322

1.15

3.91

3.1

2.9

—

(3044009) aPTT.lupus sensitive (LA screen)

4.18

3.88

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

307

1.77

3.85

1.6

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

110

747

1.49

3.83

2.2

2.0

g/l

1.4

0.14

650

(40761511) CBC panel - Blood by Automated count

3093

30158

1.25

3.81

11.7

9.7

—

(3045414) Leukocytes [Presence] in Urine

139

989

1.42

3.81

1.5

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

533

4533

1.21

3.80

1.5

nmol/l

20.4

20.3

0.09

452

4050

(3000850) Epithelial cells [#/volume] in Urine

551

4703

1.20

3.78

2.5

2.4

e6/l

6.9

6.2

0.46

499

4134

(3020779) Urea [Moles/volume] in Serum or Plasma

225

1732

1.32

3.77

9.5

8.6

mmol/l

7.9

0.05

217

1663

(3026008) Bacteria identified in Urine by Culture

651

5643

1.19

3.77

2.4

2.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

428

3571

1.23

3.70

2.7

2.4

umol/l

13.9

14.4

0.65

398

3327

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

386

3186

1.24

3.69

2.0

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

723

6335

1.18

3.69

2.4

2.3

umol/l

1637.6

3600.4

1.58

646

5720

(3015377) Calcium [Moles/volume] in Serum or Plasma

829

7345

1.17

3.68

2.8

3.1

mmol/l

2.3

1.13

713

6676

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

148

2.10

3.68

1.0

1.1

u/ml

8.1

12.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.48

3.62

1.2

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.48

3.62

1.2

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

139

999

1.41

3.61

1.7

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

170

2.01

3.58

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1117

10140

1.15

3.57

3.1

3.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

137

987

1.40

3.52

8.5

10.1

mmol/l

24.5

24.3

0.26

132

932

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

252

1992

1.29

3.49

2.9

2.4

g/l

0.2

0.61

242

1866

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

110

763

1.46

3.48

5.5

3.7

mg/l

1.4

1.3

1.19

105

724

(3015736) pH of Urine

1082

9816

1.15

3.47

2.9

—

5.9

—

(3000330) Specific gravity of Urine by Test strip

125

890

1.42

3.44

3.2

3.0

—

(3016750) Collection duration of Urine

126

2.15

3.41

2.9

2.2

min

513.6

506.7

0.14

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2870

27845

1.18

3.35

3.9

3.6

mmol/l

1.4

3.03

2693

26580

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

210

1.87

3.35

1.1

ratio

1.1

1.0

0.48

(3004789) Transferrin [Mass/volume] in Serum or Plasma

388

3241

1.22

3.33

2.7

2.4

g/l

2.4

0.17

358

3019

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

110

1544

0.70

3.31

1.7

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

359

2977

1.23

3.30

2.8

2.5

23.2

24.4

0.96

302

2597

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.54

3.29

6.2

6.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

416

1.60

3.26

3.2

3.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

774

6880

1.16

3.26

5.1

4.3

—

(3010813) Leukocytes [#/volume] in Blood

3308

32596

1.36

3.25

18.0

15.8

e9/l

6.7

6.6

1.13

3234

31903

(3002582) Erythrocytes [#/volume] in Urine

776

6902

1.16

3.24

3.2

2.8

e6/l

29.5

109.4

2.20

609

5200

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

370

1.63

3.24

1.6

1.5

—

(3002256) Pathology report gross observation

373

3113

1.22

3.23

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

294

1.71

3.23

1.4

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.39

3.22

2.7

2.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.39

3.22

2.7

2.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.39

3.22

2.7

2.6

—

(3017732) Neutrophils [#/volume] in Blood

245

1953

1.27

3.20

2.2

2.4

e9/l

4.3

4.2

0.31

198

1653

(3000963) Hemoglobin [Mass/volume] in Blood

3308

32602

1.36

3.19

18.0

15.8

g/l

138.6

138.8

0.39

3260

32299

(3026361) Erythrocytes [#/volume] in Blood

3306

32583

1.35

3.15

17.9

15.7

e12/l

4.6

0.16

3229

31920

(3007461) Platelets [#/volume] in Blood

3302

32538

1.35

3.15

18.0

15.7

e9/l

260.0

258.8

0.56

3233

31911

(3035941) MCH [Entitic mass]

3305

32574

1.35

3.13

17.8

15.6

30.1

0.10

3255

32280

(36304419) Bacteria [Presence] in Urine

712

6310

1.16

3.11

3.1

2.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

599

1.48

3.10

6.6

iu/ml

386.8

673.5

—

(3024731) MCV [Entitic volume]

3305

32577

1.35

3.10

17.8

15.6

89.9

0.12

3256

32284

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

291

1.69

3.07

1.4

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2876

27955

1.17

3.06

3.9

3.6

mmol/l

4.8

1.75

2701

26750

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

140

1039

1.36

3.06

1.4

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

345

1.63

3.05

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

490

4220

1.19

3.05

2.7

ug/g

107.5

112.6

0.19

387

3438

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

101

709

1.44

3.04

1.2

1.3

u/ml

3.4

3.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

2900

28220

1.17

2.98

12.1

11.4

40.8

41.1

0.77

2295

23641

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

102

721

1.43

2.97

1.2

1.3

u/ml

14.6

10.0

0.23

121

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

107

2.16

2.96

2.5

2.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

107

2.16

2.96

2.5

2.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

107

2.16

2.96

2.5

2.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

107

2.16

2.96

2.5

2.3

—

(3020650) Glucose [Presence] in Urine

2.28

2.93

1.3

1.4

—

(3011412) CD3 cells [#/volume] in Blood

303

1.66

2.92

2.6

2.7

e9/l

1.2

1.3

0.37

172

(3025468) Yersinia sp identified in Specimen by Organism specific culture

289

1.67

2.88

1.4

1.5

—

(3018095) Leukocytes [#/volume] in Urine

919

8338

1.14

2.86

3.6

3.3

e6/l

78.1

65.6

0.20

655

5701

(3005988) Vibrio sp identified in Specimen by Organism specific culture

290

1.66

2.84

1.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

290

1.66

2.84

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

290

1.66

2.84

1.4

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.30

2.84

1.2

96.7

93.6

0.23

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.30

2.84

1.2

—

(3028433) Virus identified in Specimen by Culture

2.34

2.81

1.4

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

219

1752

1.27

2.81

1.5

1.6

mu/l

255.8

292.1

1.36

190

1596

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2769

26880

1.15

2.80

3.5

3.3

mmol/l

1.4

1.3

1.35

2600

25610

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

103

2.14

2.80

1.2

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

242

1961

1.25

2.78

3.6

3.5

pmol/l

4.5

4.6

1.17

222

1769

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.31

2.74

2.6

2.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

802

7239

1.14

2.69

1.3

u/ml

2.5

1.6

0.70

230

2169

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

105

2.10

2.68

1.2

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

124

924

1.35

2.68

1.9

2.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

155

1200

1.31

2.59

1.9

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

222

1.72

2.57

2.7

2.3

—

(3009508) Creatinine [Moles/volume] in Urine

751

6771

1.14

2.55

4.1

3.4

mmol/l

8.1

8.6

2.28

630

5933

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2888

28170

1.15

2.52

4.1

3.8

mmol/l

2.9

0.74

2688

26797

(3014111) Lactate [Moles/volume] in Serum or Plasma

216

1751

1.25

2.50

6.6

7.5

mmol/l

1.2

1.3

2.88

206

1685

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

653

1.40

2.49

1.9

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

298

2501

1.21

2.48

1.4

iu/l

24.6

21.8

0.71

249

2162

(3002385) Erythrocyte distribution width [Ratio]

2547

24653

1.13

2.46

14.0

13.1

13.4

0.18

2493

24214

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

107

795

1.36

2.39

1.2

1.3

u/ml

52.2

23.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.61

2.35

1.8

3.0

—

(40768806) Pleura Pathology biopsy report

118

1.96

2.35

1.7

1.5

—

(3000492) Spirometry study

378

3260

1.18

2.34

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

214

1.69

2.32

4.8

3.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1014

9367

1.12

2.28

3.3

u/l

30.8

31.5

0.29

968

8935

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

125

958

1.32

2.28

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1263

11807

1.11

2.28

3.9

3.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

130

1004

1.31

2.25

2.4

2.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

286

1.58

2.25

1.5

1.8

promille

1.5

1.4

0.19

224

(21494755) Public health laboratory ask at order entry panel

453

5136

0.86

2.23

1.3

—

(3025941) Bacteria identified in Stool by Culture

223

1843

1.22

2.20

1.3

1.2

—

(3000991) Gas panel - Venous blood

208

1707

1.23

2.19

8.9

8.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

110

834

1.33

2.18

2.5

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

369

1.50

2.17

1.8

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

128

992

1.30

2.17

9.8

11.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.24

2.17

1.1

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

234

1.63

2.16

2.7

2.3

12.1

14.6

0.59

126

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

4.29

2.15

2.7

2.1

—

(3024932) HLA-DR beta [Type]

108

1.95

2.15

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

2.17

2.14

1.4

1.2

u/l

16.4

11.3

0.73

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

402

3514

1.16

2.12

1.9

—

(3012441) Differential panel - Pleural fluid

116

1.90

2.10

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

398

1.47

2.07

1.2

1.1

g/l

1.4

0.51

366

(3001019) Free T4 and TSH panel - Serum or Plasma

210

2521

0.82

2.04

1.7

1.6

—

(3002032) Base excess in Venous blood by calculation

218

1814

1.22

2.03

4.4

4.2

mmol/l

1.7

1.8

0.29

181

1478

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

101

766

1.33

2.02

2.3

mg/l

9.4

10.7

1.00

725

(3033658) Prothrombin time (PT) actual/Normal

696

6335

1.12

2.02

4.0

3.7

94.6

95.0

0.17

679

6163

(1175426) CD3 cells/100 lymphocytes in Blood

239

1.60

2.01

2.7

2.3

73.9

73.7

0.03

231

(4024509)

140

1.79

2.00

1.5

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

681

1.35

1.99

2.3

2.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

568

5111

1.13

1.99

1.3

iu/ml

26.8

24.3

0.22

168

1541

(3017143) Hepatitis C virus Ab [Presence] in Serum

515

4605

1.14

1.98

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

572

1.37

1.95

1.7

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.55

1.94

1.0

1.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.75

1.93

2.8

2.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

144

1153

1.26

1.92

1.2

1.3

u/ml

0.2

1.1

—

107

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

128

1.80

1.89

1.0

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

516

1.38

1.88

1.3

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

237

2005

1.20

1.88

2.8

1.6

1.7

0.71

208

1809

(3004809) Band form neutrophils/100 leukocytes in Blood

308

1.50

1.87

2.9

3.3

0.8

1.5

2.17

251

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

751

1.31

1.85

2.1

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.03

1.85

2.2

2.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.53

1.83

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.53

1.83

2.7

2.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

130

1.77

1.81

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

546

1.36

1.80

3.5

3.2

nmol/l

0.8

0.04

475

(3013139) Helicobacter pylori Ag [Presence] in Stool

216

1820

1.20

1.80

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

659

1.33

1.79

2.1

ug/l

1.4

1.8

0.26

598

(4034850)

851

0.72

1.77

9.6

8.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

131

1.76

1.77

2.2

1.7

nmol/l

1.7

1.2

0.79

106

(3024471) HLA-A [Type]

109

1.84

1.77

1.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

333

2915

1.16

1.76

2.9

2.6

umol/l

7.1

7.2

0.01

278

2493

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.09

1.75

1.1

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

124

1.78

1.75

1.0

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

338

1.46

1.75

2.2

2.6

mmol/l

7.1

7.2

0.12

331

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.98

1.74

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

1.70

0.0

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

104

1.83

1.67

2.5

2.2

—

(40768446) Kidney Pathology biopsy report

134

1.72

1.66

2.0

1.6

—

(3012544) pH of Venous blood

221

1883

1.19

1.65

4.5

4.2

—

7.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

165

1368

1.22

1.65

2.4

2.3

g/l

66.7

67.6

0.84

157

1282

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

149

1223

1.23

1.64

2.3

2.2

u/l

37.6

39.7

0.60

138

1134

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

608

1.32

1.63

1.1

au/ml

9.0

12.8

—

(4010399)

194

1636

1.20

1.63

1.5

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

168

1398

1.21

1.62

1.4

u/l

8.2

8.4

0.07

133

1146

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.33

1.60

1.2

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

128

1.72

1.60

1.6

1.4

e6/l

1136.8

2600.6

2.85

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.50

1.59

1.1

1.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

239

2057

1.17

1.59

7.3

8.3

kpa

5.2

5.1

0.57

228

1972

(3027801) Oxygen [Partial pressure] in Arterial blood

239

2057

1.17

1.59

7.3

8.3

kpa

12.9

13.1

0.31

230

1975

(3018677) aPTT in Platelet poor plasma by Coagulation assay

359

3185

1.14

1.59

2.1

2.2

29.8

29.6

0.20

351

3077

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

614

5627

1.11

1.58

3.4

3.1

ug/l

2.0

1.6

0.63

536

5167

(1617658) Protocol used for examination of sentinel lymph nodes

173

0.46

1.57

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

525

1.34

1.57

2.5

2.3

umol/l

5.3

6.8

0.50

386

(3036489) Thrombin time

129

1049

1.24

1.56

2.1

2.2

20.4

20.9

0.94

109

879

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.43

1.53

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

545

1.33

1.53

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

117

944

1.25

1.52

2.2

93.7

95.1

0.27

106

866

(3044941) Cell count panel - Synovial fluid

334

0.60

1.52

1.2

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.34

1.52

5.2

2.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.34

1.52

3.0

2.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

169

1418

1.20

1.51

5.0

4.2

ng/l

106.2

83.8

1.06

153

1294

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.60

1.51

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

366

1.40

1.51

2.2

2.5

mmol/l

1.3

1.5

1.00

356

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

162

1.61

1.49

3.2

3.1

u/ml

1136.0

950.9

0.17

162

(3048929) Epstein Barr virus Ab [Presence] in Serum

150

1247

1.21

1.48

1.3

—

(3003396) Base excess in Arterial blood by calculation

238

2061

1.17

1.48

7.4

8.3

mmol/l

0.9

1.0

0.12

201

1612

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.00

1.48

1.3

1.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.44

1.47

1.8

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

702

6503

1.10

1.47

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

252

1.47

1.45

1.1

mg/l

279.7

277.5

0.07

233

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

252

1.47

1.45

1.8

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

169

1425

1.20

1.45

1.6

1.7

mg/l

3.4

3.9

0.32

126

968

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

102

1.77

1.44

1.2

—

(36660697) Celiac disease serology panel - Serum

290

2555

1.15

1.44

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

560

1.31

1.43

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

276

2427

1.15

1.41

6.4

7.3

mmol/l

105.0

104.5

1.13

270

2373

(1002224) Polysomnography panel

210

1809

1.17

1.41

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

509

1.32

1.41

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

132

1091

1.22

1.40

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

222

1.49

1.38

2.6

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.61

1.36

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

223

1.48

1.36

4.7

6.1

mmol/l

12.0

7.1

0.59

191

(3023520) Reticulocytes [#/volume] in Blood

164

1389

1.19

1.35

2.8

2.9

e9/l

68.7

72.0

0.57

122

1017

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

273

1.43

1.35

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

315

1.40

1.35

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

523

1.31

1.33

1.1

118.7

115.9

0.38

479

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.04

1.32

1.5

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

136

1.62

1.32

1.1

—

(4035726)

206

1784

1.16

1.31

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

126

1045

1.21

1.31

5.4

4.6

mmol/l

24.0

24.2

0.40

114

972

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.50

1.30

1.2

—

(3019150) Specific gravity of Urine by Refractometry

498

5422

0.90

1.29

3.4

3.3

kg/l

1.0

1.59

717

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

464

1.32

1.29

2.4

2.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.36

1.29

1.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

185

1.52

1.29

2.5

3.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.09

1.27

1.2

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

874

8227

1.08

1.27

2.0

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

379

1.35

1.27

1.7

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

227

1.46

1.26

2.6

2.9

e9/l

0.3

0.2

0.31

192

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

170

1.53

1.25

1.0

103.6

95.3

0.65

135

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

115

1.66

1.24

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

476

1.31

1.24

3.3

3.5

u/ml

0.3

0.03

252

(3024869) Neuronal Ab [Presence] in Serum

2.40

1.24

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

351

0.65

1.24

19.1

12.9

nmol/l

890.0

833.6

0.23

338

(3017446) Testosterone [Moles/volume] in Serum or Plasma

297

2653

1.13

1.23

2.5

2.3

nmol/l

13.4

13.5

0.03

269

2426

(44806071)

2.00

1.23

1.1

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

139

1.59

1.23

2.5

2.7

umol/l

45.7

48.4

0.22

123

(3035880) pH of Pleural fluid

1.91

1.22

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.16

1.21

1.5

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

132

1.59

1.20

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

360

0.66

1.20

28.0

18.5

nmol/l

1520.3

4061.2

0.47

348

(3003740) Influenza virus B Ag [Presence] in Specimen

803

1.23

1.17

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

164

1410

1.17

1.4

1.3

miu/ml

194.1

225.8

0.69

682

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

133

1.58

1.17

1.1

1.0

u/ml

5.2

10.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

646

0.76

1.16

1.5

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

223

1.44

1.16

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

429

1.31

1.16

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

114

951

1.21

1.15

1.1

u/ml

5.8

1.7

0.80

402

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

147

1255

1.18

1.15

1.4

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

224

1.43

1.14

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

224

1.43

1.14

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

274

2451

1.13

1.2

iu/ml

162.3

146.1

0.31

105

968

(4306422)

546

1.27

1.13

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

103

1.65

1.12

2.8

2.5

e6/l

137.0

205.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.00

1.12

1.1

1.3

0.8

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

239

2123

1.14

1.10

1.8

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

245

2180

1.13

1.10

1.8

1.7

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.26

1.10

1.1

1.2

—

57.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

424

1.30

1.10

1.1

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

424

1.30

1.10

1.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

177

1.47

1.07

2.4

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

177

1.47

1.07

2.4

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

177

1.47

1.07

2.4

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

236

1.40

1.06

2.6

2.9

e6/l

616.5

551.8

0.28

196

(3002523) Influenza virus A Ag [Presence] in Specimen

804

1.21

1.06

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

279

1.37

1.05

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

516

1.26

1.05

1.2

1.1

iu/ml

16274.9

1511.1

0.42

142

(3044290) Cell count panel - Cerebral spinal fluid

624

1.24

1.04

1.4

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

779

1.21

1.04

2.1

2.0

iu/l

4.8

4.4

0.12

288

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

138

1185

1.17

1.03

1.5

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

221

1.41

1.02

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

753

1.21

1.02

1.2

1.4

mg/l

511.5

467.1

0.39

722

(3014148) Varicella zoster virus Ab [Titer] in Serum

545

1.25

1.02

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

196

1.43

1.02

3.3

3.0

54.5

55.1

0.04

134

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

333

1.33

1.01

1.4

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

690

1.22

1.01

1.8

2.4

ug/l

512.2

348.9

0.27

642

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

180

1.45

1.00

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

574

1.24

0.99

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

440

1.28

0.99

4.0

3.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

188

0.58

0.99

1.3

e6/l

1487.4

97010.2

—

138

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

521

1.25

0.98

1.3

1.2

u/ml

4.4

4.1

0.07

237

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

650

6112

1.08

0.98

2.2

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

693

1.22

0.98

1.6

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

212

0.61

0.98

1.9

3.0

35.6

44.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

481

0.75

0.98

1.4

1.7

e6/l

4168.9

12827.5

3.37

356

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

198

1.42

0.97

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

576

1.24

0.97

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

116

1.55

0.96

1.7

1.4

e6/l

38725.6

34885.0

0.07

(40758558) Short blood count panel - Blood

698

6590

1.07

0.95

6.3

7.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.77

0.94

1.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.89

0.94

1.0

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

125

1.52

0.93

1.4

1.5

u/field

1.0

5.3

1.68

(3020891) Body temperature

711

0.80

0.93

4.2

4.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

154

1347

1.15

0.93

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1027

0.83

0.92

1.3

—

(4038314)

1.73

0.92

1.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

142

1.48

0.92

1.5

2.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

134

1.50

0.91

1.2

g/l

0.3

0.65

106

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

428

1.27

0.91

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

287

1.33

0.91

1.2

1.5

pmol/l

283.8

327.8

0.42

224

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

126

1.51

0.91

1.3

1.2

111.1

113.8

0.16

113

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

126

1.51

0.91

1.2

1.1

92.3

93.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

645

1.21

0.91

1.6

1.5

u/ml

107.0

105.1

0.10

131

(3016018) Differential panel - Cerebral spinal fluid

331

1.30

0.91

1.6

1.5

—

(44813793)

244

1.36

0.90

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

305

1.32

0.90

1.2

1.7

mu/l

49.0

62.2

0.48

274

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

253

1.35

0.90

2.5

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

323

1.30

0.89

2.6

3.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

575

1.22

0.87

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

110

943

1.17

0.87

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

357

3293

1.09

0.87

2.3

2.2

ug/l

0.6

0.11

167

1553

(3051593) INR in Capillary blood by Coagulation assay

1.86

0.87

1.1

11.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.82

0.85

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

120

1.50

0.85

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

187

1.39

0.85

1.0

1.1

miu/ml

1485.3

1532.1

0.07

187

(3006184) Hemoglobin [Mass/volume] in Capillary blood

424

1.25

0.84

2.7

2.1

g/l

136.8

133.7

0.40

313

(3006922) Hepatitis E virus Ab [Presence] in Serum

248

1.33

0.83

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

121

1.49

0.82

1.2

1.3

96.3

95.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.74

0.82

2.0

1.7

—

(3003694) ABO and Rh group [Type] in Blood

862

8238

1.06

0.82

1.6

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

313

3396

0.91

0.81

2.1

1.9

—

(3027944) Amphetamines [Presence] in Urine

209

2312

0.90

0.80

2.5

2.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

207

1.36

0.79

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.82

0.79

1.3

2.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

100

861

1.17

0.78

1.4

1.3

titre

171.8

82.0

0.83

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

148

1.42

0.77

1.7

1.8

mg/l

6.7

3.0

1.01

139

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

123

1.47

0.77

1.2

1.1

106.5

107.8

0.06

104

(3006245) CD3-CD19+ cells/100 cells in Blood

140

1.43

0.76

3.0

2.4

10.1

8.8

0.27

134

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

226

1.33

0.76

1.3

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

374

3484

1.08

0.75

3.1

2.6

e6/l

3.1

0.02

205

1763

(3004716) Salmonella sp identified in Stool by Organism specific culture

198

1790

1.11

0.75

1.5

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.08

0.74

1.4

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

227

1.32

0.74

1.7

2.1

32.6

32.5

0.05

227

(3021901) Oxygen saturation in Capillary blood

351

1.26

0.74

3.2

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

201

1.35

0.74

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

108

1.48

0.73

1.8

1.5

—

(4146454)

167

1.38

0.73

2.6

2.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

552

1.20

0.72

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.00

0.72

1.0

u/ml

0.1

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

581

5508

1.07

0.72

2.1

1.9

—

(3024263) Appearance of Synovial fluid

108

0.55

0.72

1.2

2.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

308

1.27

0.72

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

114

999

1.15

0.72

1.0

1.1

u/ml

1.5

3.2

1.50

154

(3049717) Cytology report of Urine Cyto stain

526

1.20

0.71

1.8

2.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

229

1.31

0.71

1.9

1.6

52.6

54.0

0.07

149

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.92

0.70

1.0

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.55

0.69

1.1

1.2

—

(3014271) Vancomycin [Susceptibility]

1.55

0.69

2.7

2.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

217

1982

1.10

0.69

1.4

1.3

au/ml

65.3

36.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.53

0.69

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.67

0.68

1.4

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

127

1.42

0.67

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

196

1.33

0.67

1.8

1.6

mmol/l

5.9

6.5

0.76

141

(3014051) Protein [Presence] in Urine by Test strip

438

1.21

0.67

1.9

—

(3028626) Oxygen [Partial pressure] in Capillary blood

503

1.20

0.66

3.9

2.4

kpa

8.9

8.8

0.07

474

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.59

0.65

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

120

1.42

0.64

3.8

5.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

279

1.26

0.62

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

199

1.31

0.62

1.1

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

185

1688

1.10

0.62

1.1

titre

274.0

218.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

572

1.17

0.61

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.59

0.61

1.0

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

204

1872

1.10

0.61

2.3

ml/min/173m2

76.1

77.4

0.17

699

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

422

3988

1.07

0.60

3.6

3.2

ng/l

468.8

452.6

0.02

257

2440

(3016879) Cocaine [Presence] in Urine

200

2176

0.91

0.60

3.4

2.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

105

1.43

0.60

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

105

930

1.13

0.60

2.0

1.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

174

1.32

0.60

1.7

1.6

umol/l

29.8

24.3

0.32

166

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

231

2137

1.09

0.58

2.5

2.3

au/ml

16.2

21.9

0.90

202

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

726

1.15

0.57

1.6

1.4

nmol/l

0.6

0.5

0.19

613

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.48

0.57

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.48

0.57

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.48

0.57

1.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

347

1.21

0.56

1.3

—

47.1

—

(3048879) Bone marrow aspiration report

1.62

0.55

1.8

3.6

—

(3047189) Immunofixation for 24 hour Urine

1.54

0.55

1.3

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.54

0.55

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

246

2641

0.93

0.55

2.1

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

486

1.18

0.55

3.1

2.6

ug/min

87.3

156.0

0.84

317

(3011648) Oxygen content in Venous blood

195

1.28

0.54

3.2

4.1

12.9

11.3

1.02

195

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

195

1.28

0.54

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

216

0.74

0.53

4.4

3.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

216

0.74

0.53

8.8

6.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

331

1.21

0.53

1.1

1.7

—

36.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.49

0.53

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.49

0.53

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

722

1.14

0.53

1.1

u/ml

4.1

4.4

0.07

293

(3003181) Sodium [Moles/volume] in Urine

277

1.23

0.52

1.1

1.5

mmol/l

66.1

68.7

0.08

232

(3010726) Horse dander IgE Ab [Units/volume] in Serum

855

1.13

0.52

1.1

u/ml

1.3

2.6

0.75

216

(3034860) Kappa light chains.free [Mass/volume] in Serum

424

1.18

0.52

2.9

3.1

mg/l

40.4

57.7

0.51

334

(3021879) Hepatitis B virus core Ab [Presence] in Serum

330

3113

1.07

0.52

1.4

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.50

0.51

2.2

2.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

425

1.18

0.51

2.8

3.1

mg/l

27.2

38.4

0.81

335

(3044927) Protein electrophoresis panel - Urine

144

1.32

0.50

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

127

1.34

0.49

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

101

1.39

0.49

2.2

3.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

234

1.24

0.49

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

198

1.26

0.49

2.1

2.3

—

(40768795) Lymph node Pathology biopsy report

216

1.25

0.49

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

175

1616

1.09

0.49

3.9

4.2

ug/l

8.2

43.0

0.91

118

1228

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

374

3550

1.06

0.49

2.8

2.6

mmol/l

2.4

0.09

323

3093

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.56

0.49

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

219

2347

0.93

0.48

3.5

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.40

0.48

3.1

2.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

172

1.28

0.48

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

309

1.20

0.46

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

236

1.23

0.46

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

120

1.33

0.46

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.60

0.45

1.6

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.43

0.45

1.3

1.1

105.4

107.7

0.11

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.40

0.45

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

780

1.12

0.45

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

174

1.27

0.44

4.0

3.9

—

(40768800) Prostate Pathology biopsy report

183

1.26

0.44

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.37

0.44

1.3

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

167

1799

0.92

0.44

3.5

2.4

—

(21494434) Karyotype in Bone marrow

148

1.29

0.43

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

536

1.14

0.43

1.3

1.2

u/ml

5.2

2.8

0.28

176

(3029396) Erythrocyte agglutination [Presence] in Blood

128

0.70

0.43

2.0

3.1

—

(3027008) Opiates [Presence] in Urine

220

2343

0.93

0.43

3.2

2.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.61

0.43

1.8

1.1

—

(4015189)

1.61

0.43

2.6

3.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.61

0.43

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

524

5043

1.05

0.42

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.66

0.42

1.8

—

(3001556) Androgen free Index in Serum or Plasma

1.40

0.42

2.1

1.3

—

(3051651) Icteric interference index of Serum or Plasma

140

1.29

0.42

2.8

3.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.52

0.41

1.8

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

231

1.21

0.41

1.6

1.2

titre

140.0

225.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

105

1.33

0.41

1.2

1.0

—

(4212803)

0.00

0.40

0.0

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.40

0.0

1.1

—

1.5

—

(3034614) HLA Ag [Interpretation]

0.00

0.40

0.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

114

1.32

0.40

2.2

2.0

—

(4268621)

361

1.17

0.40

2.6

2.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

146

1574

0.92

0.40

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.47

0.40

1.6

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.47

0.40

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1086

0.91

0.40

1.3

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

390

0.84

0.40

1.5

1.3

pmol/l

83.8

149.2

—

121

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

141

1.28

0.40

1.3

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

141

1.28

0.40

1.4

1.5

nmol/l

136.5

136.8

0.01

141

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

102

0.69

0.39

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.34

0.39

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.43

0.39

1.6

3.6

umol/l

31.6

48.6

—

(3005033) Fetal Nuchal fold Thickness US

1084

0.91

0.39

1.3

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.41

0.39

1.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

475

1.14

0.39

3.8

3.2

umol/l

40.7

35.0

0.73

414

(3000093) Morphology [Interpretation] in Blood Narrative

187

1.23

0.39

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

741

1.11

0.38

1.4

1.2

u/ml

271.2

259.2

0.12

482

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.38

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.39

0.38

1.0

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

219

2320

0.94

0.38

3.2

2.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

326

1.17

0.38

1.7

1.5

mmol/l

7.6

7.9

0.26

210

(3023430) Cat dander IgE Ab [Units/volume] in Serum

666

1.11

0.38

1.1

u/ml

3.5

6.0

0.64

273

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

252

1.19

0.37

2.1

3.1

e6/l

889.3

768.6

0.32

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

243

1.20

0.37

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

215

2029

1.06

0.37

2.3

2.4

u/l

3430.4

4742.7

0.37

756

(3014765) Yersinia sp identified in Stool by Organism specific culture

858

1.10

0.37

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

161

1.24

0.37

3.3

2.9

nmol/l

0.8

0.9

0.49

123

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

259

2460

1.06

0.36

5.4

5.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

510

4926

1.04

0.36

1.7

1.9

1.4

0.76

449

4479

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

171

1.23

0.35

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

171

1.23

0.35

1.6

1.7

120.7

119.9

0.02

164

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.63

0.35

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

842

1.10

0.35

1.0

1.1

u/ml

0.6

1.2

1.40

387

(4094501)

613

1.11

0.34

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

101

1096

0.92

0.34

6.7

8.1

mmol/l

25.4

24.4

1.45

1023

(3030313) Adrenal Ab [Titer] in Serum

1.36

0.34

1.2

1.1

—

(4198724)

276

0.83

0.34

1.4

3.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

172

1.22

0.34

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

892

1.09

0.34

1.1

u/ml

8.1

6.7

0.25

513

(3043238) Trisomy 21 risk [Likelihood] in Fetus

104

1125

0.92

0.33

1.3

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.67

0.33

2.3

2.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.35

0.32

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

332

1.15

0.32

1.1

1.2

mg/l

37.4

37.8

0.03

271

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

119

1.26

0.31

1.1

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

119

1.26

0.31

1.3

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

132

1410

0.93

0.31

1.8

2.1

ug/l

6.7

6.4

0.08

115

1264

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

386

3723

1.04

0.31

3.1

2.4

e6/l

0.8

1.1

0.61

217

1993

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.71

0.30

1.4

1.3

—

927.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

324

0.86

0.29

4.5

4.6

u/ml

35.0

88.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

113

1057

1.07

0.28

1.8

1.6

iu/ml

0.0

0.3

1.80

208

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

709

1.09

0.28

1.3

1.4

u/l

16.7

21.1

1.04

599

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.28

1.0

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

661

1.09

0.28

1.5

e6/l

298.0

2320.4

1.19

538

(42529406) Shigella sp [Presence] in Stool by Culture

864

1.08

0.27

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.17

0.27

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

214

1.17

0.27

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.17

0.27

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.27

0.27

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

662

1.09

0.27

1.5

e6/l

13.6

25.2

0.67

512

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

205

1.17

0.27

1.2

1.7

—

(40758292) HTLV I+II Ab panel - Serum

1.23

0.27

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

309

1.13

0.27

1.3

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.69

0.26

1.0

—

(3017569) Oxygen content in Arterial blood

0.68

0.26

2.6

1.9

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

216

1.16

0.25

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

216

1.16

0.25

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

321

1.12

0.24

1.1

mg/l

277.8

231.4

0.82

281

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

329

0.88

0.24

1.2

u/l

23.0

35.9

0.44

281

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.15

0.24

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

217

1.15

0.24

1.0

1.1

iu/ml

17.5

7.9

—

(40768793) Breast Pathology biopsy report

569

0.91

0.24

1.4

1.3

—

(3004451) EKG impression Narrative

0.74

0.24

1.0

1.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.32

0.23

1.0

1.2

39.2

34.2

—

(3008898) HLA-B27 [Presence]

154

1468

1.05

0.23

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.24

0.23

2.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.24

0.23

2.4

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.76

0.22

1.9

1.5

ug/l

7.3

8.3

—

(3006462) Nitrate [Presence] in Urine

0.76

0.22

2.4

2.3

—

(3022621) pH of Urine by Test strip

148

1412

1.05

0.22

2.4

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.21

0.0

1.4

—

2110.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.21

0.0

1.3

—

0.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

131.7

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.21

0.0

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

604

1.08

0.21

1.0

1.1

u/ml

0.3

0.7

0.33

140

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.3

—

(4211845)

103

0.78

0.21

2.3

—

(3033799) Differential panel - Peritoneal fluid

1.16

0.21

2.8

2.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

489

1.09

0.20

5.7

6.5

umol/l

384.5

381.6

0.04

436

(3037556) Urate [Mass/volume] in Serum or Plasma

1.25

0.20

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

403

4130

0.97

0.20

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

859

1.06

0.20

1.1

—

(3019060) Gas panel - Arterial blood

117

1113

1.05

0.20

4.9

5.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

155

1.16

0.19

1.8

—

(3024928) Oxygen saturation in Venous blood

471

1.08

0.19

3.4

3.9

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.18

0.19

1.0

1.1

nmol/l

3.6

6.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

207

0.87

0.19

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

579

1.07

0.18

1.9

2.0

g/l

3.0

3.1

0.28

457

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

347

1.10

0.18

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

204

2110

0.96

0.18

15.6

14.6

inr

1.2

1.1

0.17

346

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

562

1.07

0.17

1.4

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

115

1102

1.05

0.16

1.5

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

1006

0.95

0.16

4.9

3.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

603

1.06

0.16

2.1

2.0

g/l

3.6

3.8

0.73

439

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

603

1.06

0.16

2.1

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

116

1209

0.96

0.15

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

604

1.06

0.15

2.1

2.0

g/l

7.1

7.2

0.14

469

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

197

1.12

0.15

1.3

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

1.13

0.15

1.0

1.1

—

(40768441) Liver Pathology biopsy report

192

0.88

0.14

2.1

1.5

—

(3000012) Reticulocyte production index

1.08

0.14

1.3

1.6

—

(3021788) Differential panel - Synovial fluid

372

1.08

0.14

1.6

1.5

—

(3045142) Bone marrow Pathology biopsy report

208

1.11

0.14

1.3

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.82

0.13

1.8

2.6

umol/l

22.2

16.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

132

1276

1.04

0.13

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

608

1.05

0.13

3.9

3.8

u/ml

57.7

334.2

1.27

521

(3009871) Measles virus Ab [Titer] in Serum

142

1.13

0.12

1.9

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

662

0.95

0.12

1.3

ug/l

2.8

2.9

0.08

606

(3035933) Granulocytes/100 leukocytes in Blood

123

1.14

0.12

1.5

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

493

1.06

0.11

3.3

3.0

mg/l

25.8

24.0

0.14

308

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

143

1.12

0.11

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

536

0.95

0.10

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

397

1.06

0.10

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

473

4669

1.02

0.10

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

248

2433

1.02

0.10

2.8

2.7

u/l

38.0

40.0

0.15

217

2128

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

453

0.95

0.10

1.5

1.4

mmol/l

6.7

6.9

0.11

340

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

145

1.10

0.09

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.07

0.08

1.0

1.1

—

(4133840)

107

1.12

0.08

1.2

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

541

5464

0.99

0.08

3.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.83

0.08

1.4

1.5

—

(40765096) Chromosome analysis panel by Banding

0.81

0.08

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

123

0.89

0.08

1.0

1.4

—

(3017509) Phencyclidine [Presence] in Urine

0.84

0.07

1.0

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

753

0.97

0.07

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.07

0.07

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

184

0.92

0.07

2.3

1.5

24.2

34.2

0.58

116

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

621

0.97

0.07

1.8

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

629

1.03

0.07

1.1

—

(40761535) Cells panel - Urine sediment

162

1650

0.98

0.07

3.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

296

0.95

0.07

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.83

0.07

2.6

2.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

128

1.09

0.06

1.1

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

126

1285

0.98

0.06

1.3

1.4

—

(3023410) Appearance of Cerebral spinal fluid

325

0.95

0.06

1.7

1.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

109

1.10

0.06

1.4

1.6

pmol/l

12.5

14.8

1.02

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

184

1813

1.02

0.06

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

119

1.09

0.06

1.4

1.1

u/ml

78.0

50.8

0.52

114

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

280

2829

0.99

0.05

1.4

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

557

5606

0.99

0.05

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

222

0.95

0.05

2.0

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

384

0.96

0.05

1.1

1.3

—

(3011288) Drugs identified in Urine by Screen method

155

1529

1.01

0.04

5.4

3.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

133

1350

0.98

0.04

1.3

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

191

0.94

0.04

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

288

1.04

0.04

1.3

1.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

298

1.04

0.04

1.0

1.1

u/ml

0.2

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.10

0.04

1.8

1.5

2.4

4.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

322

0.96

0.04

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

127

1287

0.99

0.04

1.3

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

458

1.03

0.03

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

127

1286

0.99

0.03

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

127

1286

0.99

0.03

1.3

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

230

1.04

0.03

1.0

1.1

u/l

0.9

1.0

—

103

(3025130) Human papilloma virus identified in Specimen

531

0.98

0.03

1.7

—

(4281824)

221

1.04

0.03

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

442

4400

1.01

0.03

2.8

21.0

21.3

0.13

141

1303

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

132

1.06

0.02

2.3

2.7

umol/l

304.5

162.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

610

1.02

0.02

1.0

1.1

u/ml

3.2

2.9

0.08

341

(3015183) Erythrocyte sedimentation rate

227

0.97

0.01

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

128

1289

0.99

0.01

2.4

2.7

ng/l

152.6

130.3

0.25

113

1119

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

287

0.98

0.01

1.5

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

141

1418

0.99

0.01

1.8

2.5

u/ml

63.1

36.1

0.59

136

1373

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

228

2288

1.00

0.01

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

135

1357

0.99

0.00

1.3

1.4

—

(3008295) Osmolality of Serum or Plasma

246

0.98

0.00

1.6

mosm/kgh2o

286.8

284.5

0.35

188

(3037756) Immunofixation for Serum or Plasma

284

1.02

0.00

2.2

1.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

128

1.02

0.00

1.4

1.8

129.2

139.8

0.24

119

(44790047)

262

0.99

0.00

1.5

1.6

—

(44790048)

262

0.99

0.00

1.5

1.6

—

(44790049)

262

0.99

0.00

1.5

1.6

—

(44806118)

262

0.99

0.00

1.5

1.6

—

(3034426) Prothrombin time (PT)

125

1.04

0.00

1.5

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

308

1.01

0.00

1.0

1.1

u/ml

0.4

0.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

205

1.02

0.00

3.2

2.2

—

(4027681)

265

0.98

0.00

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

151

0.99

0.00

1.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

844

1.00

0.00

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

754

0.99

0.00

1.5

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

316

1.01

0.00

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

304

0.99

0.00

1.2

2.1

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.4

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.2

—

(3017704) Immunofixation for Urine

0.90

0.00

3.0

1.8

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

30.9

—

(3029075) Extractable nuclear Ab panel - Serum

1.01

0.00

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

1.9

—

36.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.85

0.00

2.0

1.8

mg/l

1.7

1.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

3.9

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

290.6

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.98

0.00

2.1

3.3

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.92

0.00

1.1

u/l

115.1

82.0

—

(3042517) Benzodiazepines panel - Urine

0.90

0.00

5.0

3.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

180

1.00

0.00

7.0

7.3

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.9

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.5

—

155.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1474.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.88

0.00

1.4

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

4.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

270

1.00

0.00

1.4

2.6

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.00

0.00

4.4

1.7

mmol/l

1.1

1.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

37.8

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.93

0.00

1.1

u/l

38.2

18.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

1.6

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

7.9

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_EUSTSALP and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_EUSTSALP	0.882 [0.71, 1.09]	0.255
Birth year	0.993 [0.98, 1.0]	0.125

During the follow-up period (1.1.1998 — 31.12.2019), 109 out of 3289 females with H8_EUSTSALP died.

Males

Parameter	HR [95% CI]	p-value
H8_EUSTSALP	0.873 [0.69, 1.1]	0.243
Birth year	0.99 [0.98, 1.0]	0.032

During the follow-up period (1.1.1998 — 31.12.2019), 112 out of 2993 males with H8_EUSTSALP died.

Mortality risk

Mortality risk for people of age

years, who have H8_EUSTSALP.

N-year risk	Females	Males
1	0.092%	0.177%
5	0.469%	1.006%
10	1.221%	2.684%
15	2.401%	5.315%
20	4.328%	9.138%

Relationships between endpoints

↥

Index endpoint: H8_EUSTSALP – Eustachian salpingitis and obstruction

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Eustachian salpingitis and obstruction

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints